165 related articles for article (PubMed ID: 21812425)
1. Synthesis and stereospecificity of 4,5-disubstituted oxazolidinone ligands binding to T-box riboswitch RNA.
Orac CM; Zhou S; Means JA; Boehm D; Bergmeier SC; Hines JV
J Med Chem; 2011 Oct; 54(19):6786-95. PubMed ID: 21812425
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of RNA-binding oxazolidinone derivatives.
Maciagiewicz I; Zhou S; Bergmeier SC; Hines JV
Bioorg Med Chem Lett; 2011 Aug; 21(15):4524-7. PubMed ID: 21733684
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity studies of oxazolidinone analogs as RNA-binding agents.
Means J; Katz S; Nayek A; Anupam R; Hines JV; Bergmeier SC
Bioorg Med Chem Lett; 2006 Jul; 16(13):3600-4. PubMed ID: 16603349
[TBL] [Abstract][Full Text] [Related]
4. RNA drug discovery: Conformational restriction enhances specific modulation of the T-box riboswitch function.
Armstrong I; Aldhumani AH; Schopis JL; Fang F; Parsons E; Zeng C; Hossain MI; Bergmeier SC; Hines JV
Bioorg Med Chem; 2020 Oct; 28(20):115696. PubMed ID: 33069065
[TBL] [Abstract][Full Text] [Related]
5. Anisotropy studies of tRNA-T box antiterminator RNA complex in the presence of 1,4-disubstituted 1,2,3-triazoles.
Zhou S; Acquaah-Harrison G; Bergmeier SC; Hines JV
Bioorg Med Chem Lett; 2011 Dec; 21(23):7059-63. PubMed ID: 22001091
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a 1,4-disubstituted 1,2,3-triazole binding to T box antiterminator RNA.
Zhou S; Means JA; Acquaah-Harrison G; Bergmeier SC; Hines JV
Bioorg Med Chem; 2012 Feb; 20(3):1298-302. PubMed ID: 22230198
[TBL] [Abstract][Full Text] [Related]
7. Identification of Spermidine Binding Site in T-box Riboswitch Antiterminator RNA.
Liu J; Zeng C; Hogan V; Zhou S; Monwar MM; Hines JV
Chem Biol Drug Des; 2016 Feb; 87(2):182-9. PubMed ID: 26348362
[TBL] [Abstract][Full Text] [Related]
8. 4,5-Disubstituted oxazolidinones: High affinity molecular effectors of RNA function.
Anupam R; Nayek A; Green NJ; Grundy FJ; Henkin TM; Means JA; Bergmeier SC; Hines JV
Bioorg Med Chem Lett; 2008 Jun; 18(12):3541-4. PubMed ID: 18502126
[TBL] [Abstract][Full Text] [Related]
9. Library of 1,4-disubstituted 1,2,3-triazole analogs of oxazolidinone RNA-binding agents.
Acquaah-Harrison G; Zhou S; Hines JV; Bergmeier SC
J Comb Chem; 2010 Jul; 12(4):491-6. PubMed ID: 20557032
[TBL] [Abstract][Full Text] [Related]
10. Ligand-induced changes in T box antiterminator RNA stability.
Zhou S; Acquaah-Harrison G; Jack KD; Bergmeier SC; Hines JV
Chem Biol Drug Des; 2012 Feb; 79(2):202-8. PubMed ID: 22117759
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence assays for monitoring RNA-ligand interactions and riboswitch-targeted drug discovery screening.
Liu J; Zeng C; Zhou S; Means JA; Hines JV
Methods Enzymol; 2015; 550():363-83. PubMed ID: 25605395
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence anisotropy: analysis of tRNA binding to the T box riboswitch antiterminator RNA.
Zhou S; Anupam R; Hines JV
Methods Mol Biol; 2015; 1240():143-52. PubMed ID: 25352143
[TBL] [Abstract][Full Text] [Related]
13. An evolving tale of two interacting RNAs-themes and variations of the T-box riboswitch mechanism.
Suddala KC; Zhang J
IUBMB Life; 2019 Aug; 71(8):1167-1180. PubMed ID: 31206978
[TBL] [Abstract][Full Text] [Related]
14. Interfacing medicinal chemistry with structural bioinformatics: implications for T box riboswitch RNA drug discovery.
Jentzsch F; Hines JV
BMC Bioinformatics; 2012 Mar; 13 Suppl 2(Suppl 2):S5. PubMed ID: 22536868
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, SAR and antibacterial studies on novel chalcone oxazolidinone hybrids.
Selvakumar N; Kumar GS; Azhagan AM; Rajulu GG; Sharma S; Kumar MS; Das J; Iqbal J; Trehan S
Eur J Med Chem; 2007 Apr; 42(4):538-43. PubMed ID: 17150281
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro activity of novel 1,2,4-triazolo[4,3-a]pyrimidine oxazolidinone antibacterial agents. Part II.
Khera MK; Cliffe IA; Prakash O
Bioorg Med Chem Lett; 2011 Sep; 21(18):5266-9. PubMed ID: 21835618
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel 5-(hydroxamic acid)methyl oxazolidinone derivatives.
Phillips OA; D'Silva R; Bahta TO; Sharaf LH; Udo EE; Benov L; Eric Walters D
Eur J Med Chem; 2015 Dec; 106():120-31. PubMed ID: 26536532
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds].
Meng QG; Wang Q; Liu J
Yao Xue Xue Bao; 2003 Oct; 38(10):754-9. PubMed ID: 14730898
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel oxazolidinone antimicrobial agents.
Ebner DC; Culhane JC; Winkelman TN; Haustein MD; Ditty JL; Ippoliti JT
Bioorg Med Chem; 2008 Mar; 16(5):2651-6. PubMed ID: 18077175
[TBL] [Abstract][Full Text] [Related]
20. 4-Aminoquinolines modulate RNA structure and function: Pharmacophore implications of a conformationally restricted polyamine.
Hossain MI; Myers M; Herath D; Aldhumani AH; Boesger H; Hines JV
Biochem Biophys Res Commun; 2023 Feb; 644():55-61. PubMed ID: 36630735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
